According to PDS Biotechnology
's latest financial reports the company has a price-to-book ratio of 4.95.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Year | P/B ratio | Change |
---|---|---|
2023-12-31 | 5.92 | -30.82% |
2022-12-31 | 8.55 | 134.68% |
2021-12-31 | 3.64 | 107.52% |
2020-12-31 | 1.76 | 46.77% |
2019-12-31 | 1.20 | 253.62% |
2018-12-31 | 0.3383 | -92.7% |
2017-12-31 | 4.64 | 14.5% |
2016-12-31 | 4.05 | 37.7% |
2015-12-31 | 2.94 | |
2014-12-31 | N/A |
Company | P/B ratio | differencediff. | Country |
---|---|---|---|
ORIC Pharmaceuticals
ORIC | 2.71 | -45.23% | ๐บ๐ธ USA |